432 related articles for article (PubMed ID: 25990929)
1. The impact of new trends in POCTs for companion diagnostics, non-invasive testing and molecular diagnostics.
Huckle D
Expert Rev Mol Diagn; 2015 Jun; 15(6):815-27. PubMed ID: 25990929
[TBL] [Abstract][Full Text] [Related]
2. Current and Emerging Trends in Point-of-Care Technology and Strategies for Clinical Validation and Implementation.
Wang P; Kricka LJ
Clin Chem; 2018 Oct; 64(10):1439-1452. PubMed ID: 29884677
[TBL] [Abstract][Full Text] [Related]
3. Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing.
Campbell MR
Expert Rev Mol Diagn; 2020 Jun; 20(6):637-644. PubMed ID: 32167388
[TBL] [Abstract][Full Text] [Related]
4. Enterprises and challenges in diagnostics for precision medicine: an interview with Eddie Blair.
Blair E; Raison C
Expert Rev Mol Diagn; 2015; 15(12):1521-3. PubMed ID: 26560159
[TBL] [Abstract][Full Text] [Related]
5. Developing precision medicine in a global world.
Rubin EH; Allen JD; Nowak JA; Bates SE
Clin Cancer Res; 2014 Mar; 20(6):1419-27. PubMed ID: 24634465
[TBL] [Abstract][Full Text] [Related]
6. The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe.
Wurcel V; Perche O; Lesteven D; Williams DA; Schäfer B; Hopley C; Jungwirth R; Postulka A; Pasmans R; Hermansson LL; Ott M; Glorioso V
Public Health Genomics; 2016; 19(3):137-43. PubMed ID: 27237134
[TBL] [Abstract][Full Text] [Related]
7. Precision medicine: what's all the fuss about?
Barker R
Scand J Clin Lab Invest Suppl; 2016; 245():S2-5. PubMed ID: 27542001
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testing.
Bissonnette L; Bergeron MG
Clin Microbiol Infect; 2010 Aug; 16(8):1044-53. PubMed ID: 20670286
[TBL] [Abstract][Full Text] [Related]
9. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
10. The Health Technology Assessment of companion diagnostics: experience of NICE.
Byron SK; Crabb N; George E; Marlow M; Newland A
Clin Cancer Res; 2014 Mar; 20(6):1469-76. PubMed ID: 24634470
[TBL] [Abstract][Full Text] [Related]
11. ENVIRONMENTAL SCAN ON PHARMACEUTICALS REQUIRING COMPANION DIAGNOSTICS.
Cowling T; Boucher M
Int J Technol Assess Health Care; 2016 Jan; 32(5):327-336. PubMed ID: 27955717
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.
Sager M; Yeat NC; Pajaro-Van der Stadt S; Lin C; Ren Q; Lin J
Expert Rev Mol Diagn; 2015; 15(12):1589-603. PubMed ID: 26565429
[TBL] [Abstract][Full Text] [Related]
13. Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials.
Van Heertum RL; Scarimbolo R; Ford R; Berdougo E; O'Neal M
Drug Des Devel Ther; 2015; 9():5215-23. PubMed ID: 26392755
[TBL] [Abstract][Full Text] [Related]
14. Companion diagnostics: the key to personalized medicine. Foreword.
Jørgensen JT
Expert Rev Mol Diagn; 2015 Feb; 15(2):153-6. PubMed ID: 25597758
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine--trends in molecular diagnostics: exponential growth expected in the next ten years.
Hoggatt J
Mol Diagn Ther; 2011 Feb; 15(1):53-5. PubMed ID: 21469770
[TBL] [Abstract][Full Text] [Related]
16. [Lab-on-a-chip systems in the point-of-care diagnostics].
Szabó B; Borbíró A; Fürjes P
Orv Hetil; 2015 Dec; 156(52):2096-102. PubMed ID: 26686745
[TBL] [Abstract][Full Text] [Related]
17. Nanochannel systems for personalized therapy and laboratory diagnostics.
Grattoni A; Fine D; Ziemys A; Gill J; Zabre E; Goodall R; Ferrari M
Curr Pharm Biotechnol; 2010 Jun; 11(4):343-65. PubMed ID: 20199382
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
[TBL] [Abstract][Full Text] [Related]
19. An interview with Dr. Edward Abrahams on companion and complementary diagnostics in the era of personalized medicine.
Abrahams E
Expert Rev Mol Diagn; 2020 Jun; 20(6):561-563. PubMed ID: 32148107
[No Abstract] [Full Text] [Related]
20. The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine.
Li M; Yu T; Hu YF
Stat Med; 2015 Jun; 34(14):2222-34. PubMed ID: 25779099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
